Antithrombin III, a small glycoprotein that inactivates several enzymes of the coagulation system, has been proposed as an anti-inflammatory treatment of E-coli infection and liver injury [73,74,75] as well as uveitis in a rat model [76]. The gene discussed is SERPINC1; the disease is escherichia coli infection.